Newsletter
| Promoter: | Stock Freak | Paying Party: | QTR LLC |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| PIHN | $10000 | UNKNOWN |
| Max Profit: 0.00 % | Gain at close: 0.00 % | |
| *We think that this promoter is a part of a group of promoters. | ||
 |
Good Evening Traders,
PIHN is our huge new play for Monday so put it high on your watch list!
We are kicking the fall season off with a sub-penny that has massive upside potential.
We couldn't be more thrilled to bring our readers this sub-penny play right now. Our last alert was a lot higher priced and saw gains of almost 25% in just hours.
At just $0.0002, PIHN could offer even more monstrous opportunity for profit. The stock has seen gains of 100% numerous times this month!
The best part? These gains were accumulated in ONE trading session!
If it doubles again, we want our readers benefiting from that potential move so start your research right away.
The action could start as soon as the bell rings tomorrow at 9:30AM!
Polaris International Holdings Inc. (OTC: PIHN)
www.Procannas.net
PIHN could easily dwarf all of our recent wins due to how low the stock is trading. Sub-penny stocks often times can see some of the biggest moves quickly because of how low they trade.
The company is involved with medical marijuana, an industry that was one of the fastest growing arenas last year. The legal marijuana industry brought in $2.4 billion in 2014.
So far 23 states and DC have enacted laws to legalize medical marijuana and more could be on the way.
This opens a huge doorway of opportunity for PIHN to grow within the industry!
Scientists at California Pacific Medical Center who have been researching marijuana compounds for over 20 years confirm that cannabidiol, or CBD, has the ability to switch off the DNA that causes breast and other types of cancers to metastasize. CBD is the second-most abundant cannabinoid within marijuana, but does not cause the psychotropic high of THC. - See more at: http://www.cannabiscure.info/files/breast_cancer.htm#sthash.sWRdHi9i.dpuf
"Other potentially treatable cancers that respond well to cannabis oil extract are forms of leukaemia, lung, ovarian and brain cancers, which also have high levels of ID-1. Research into other forms of cancer indicate similar results. "
Potentially millions of lives could be saved with the use of cannabinoids and this is what has our immediate attention on PIHN!
About the Company:
PIHN has a medical division called ProCannas.
ProCannas's core business focuses on the manufacture and distribution of new, pharma grade cannabinoid based products for medicinal use.
Due to changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, the doors are opening for innovation.
For those of you who are not familiar with what THC (or tetrahydrocannabinol) is, it is the chemical responsible for most of marijuana's psychological effects.
THC is illegal in most states and is the ingredient causing one to get “high”.
Laws are expected to become even more favorable for companies like PIHN which means the growth potential could be MASSIVE!
Products that do not contain THC open the door for wide market success and has given PIHN the opportunity to legally develop, patent, protect and offer to the market a proprietary non-THC based Cannatrol™ formulation called Cannatrol DM.
It is far less regulated by the Administration and FDA (Food and Drug Administration) as supplements, foods, and cosmetics.
A refined CBD completely void of THC a myriad of uses in a number of specialties including:
·Pain management
·Sports medicine
·Preventative medicine and oncology, and
·Possibly increasing the effectiveness of some chemotherapy
PIHN is developing a unique and proprietary transdermal patch capable of delivering cann abinoids directly through the skin.
This hallmark solution is intended to address a significant, unmet need for individuals requiring long-term, time released delivery.
PIHN expects that this mechanism of delivery could revolutionize the way cannabinoids are introduced into the blood stream minimizing the negative effects on lungs and other organs commonly seen in other delivery methods!
"Transdermal delivery of Cannabinoids has a global reach because diseases such as osteoporosis which affects about 52 million Americans and causes more than 8.9 million fractures worldwide annually, resulting in an osteoporotic fracture every 3 seconds, will greatly benefit from this method of delivery," stated Medical Director, Dr. Vasthi Alvarez Avila.
So what separates PIHN from competition?
The primary differences between PIHN's non-THC formulations and other non-THC products available are significant!
1st -- the company has what they believe to be the ONLY ultra-pure, pharmaceutical grade, maximum strength product available!
2nd -- some of their formulations contain enhancing ingredients and antioxidants such as vitamin C, D3 (Cannatrol VM) and various curcuminoids (Cannatrol TL). To increase absorption, the company also offer a formulation with bioperine (Cannatrol AB).
PIHN may become an innovater in a major industry and may be at the lowest levels it will ever trade at. This could be a windfall profit opportunity to not miss out on!
Hurry and start your research right away..
We are issuing a VERY STRONG ALERT on PIHN right now!
Sincerely,
TSF
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY
We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. TheStockFreak.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by [www.TheStockFreak.com] or an offer or solicitation to buy or sell any securities. TheStockFreak.com has not been compensated for this email.
None of the owners of TheStockFreak.com, or any of its members, officers, directors, contractors or employees is a licensed broker-dealer, account representative, market maker, investment banker, investment advisor, analyst or underwriter. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. TheStockFreak.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
TheStockFreak.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and TheStockFreak.com has no obligation to update any of the information provided, nor is it responsible for errors and omissions.
From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our releases or on our website may not have approved certain or any statements within the release or website. TheStockFreak.com encourages viewers to supplement the information obtained from any release or our website with independent research and other professional advice. By accessing, viewing, or using our website or communications originating from our website or any release therein, you agree that TheStockFreak.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that [www.TheStockFreak.com], its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
[www.TheStockFreak.com] uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold TheStockFreak.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. TheStockFreak.com disclaims all warranties of any kind, express or implied. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org . In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/investors/index.htm.
Questions regarding any information contained in this website may be sent to info@TheStockFreak.com To view our complete disclaimer and additional information, please visit TheStockFreak.com.
COMPANY SPECIFIC DISCLAIMER
Some of the content in this release may contain forward-looking information within the meaning of Section 27 A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the profiled companies and the value of their securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. The company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in our releases. A company's past performance does not guarantee future results. Further specific financial information, filings and disclosures as well as general investor information about the profiled companies, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org.
The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. This release may provide hyperlinks to third party websites or access to third party content. TheStockFreak.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does TheStockFreak.com control, endorse, or guarantee any content found in such sites.
TheStockFreak.com expects to be compensated $10,000 from Speak Easy Media for a profile of Polaris International Holdings Inc. (OTC: PIHN) which services include the issuance of this release and other opinions that we release concerning of Polaris International Holdings Inc. (OTC: PIHN). TheStockFreak.com has not investigated the background of Speak Easy Media, the hiring party, or Polaris International Holdings Inc. (OTC: PIHN). Viewing this newsletter should assume Speak Easy Media or affiliates of Speak Easy Media own shares of Polaris International Holdings Inc. (OTC: PIHN) of which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. TheStockFreak.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Polaris International Holdings Inc. (OTC: PIHN).
|
This message was sent to xxxxxx@gmail.com from: Stock Freak | Info@thestockfreak.com | Stock Freak | 433 plaza real suite 275 | Boca Raton , Fl 33432 |
Email Marketing by |
